How big is the North America Self-monitoring Blood Glucose Market?

The North America Self-monitoring Blood Glucose Market size is expected to reach USD 8.10 billion in 2024 and grow at a CAGR of 6.98% to reach USD 11.35 billion by 2029. Read More

What is the current North America Self-monitoring Blood Glucose Market size?

In 2024, the North America Self-monitoring Blood Glucose Market size is expected to reach USD 8.10 billion. Read More

Who are the key players in North America Self-monitoring Blood Glucose Market?

Ascensia, Arkray, Abbott, F. Hoffmann-La Roche AG and Platinum Equity (LifeScan) are the major companies operating in the North America Self-monitoring Blood Glucose Market. Read More

What years does this North America Self-monitoring Blood Glucose Market cover, and what was the market size in 2023?

In 2023, the North America Self-monitoring Blood Glucose Market size was estimated at USD 7.53 billion. The report covers the North America Self-monitoring Blood Glucose Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Self-monitoring Blood Glucose Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America Self-monitoring Blood Glucose Companies

This report lists the top North America Self-monitoring Blood Glucose companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the North America Self-monitoring Blood Glucose industry.